Symphonix Devices Vibrant "soundbridge" hearing device slated to enter clinicals in July.
This article was originally published in The Gray Sheet
Executive Summary
SYMPHONIX DEVICES VIBRANT "SOUNDBRIDGE" CLINICAL TRIALS are scheduled to begin this summer in the U.S. and Europe, the company says. San Jose, California-based Symphonix received an investigational device exemption in January for the semi-implantable microphone-amplifier-transducer system, which is designed to aid patients with moderate-to-severe hearing loss who "fall between satisfied hearing aid users and candidates for a cochlear implant, who cannot be helped at all by amplification."